Liangcheng Zhu

EGT1442, a potent and selective SGLT2 inhibitor, attenuates blood glucose and HbA(1c) levels in db/db mice and prolongs the survival of stroke-prone rats.

J. Y. Roberge, B. Seed, Yongxiang Wang, 2011, Pharmacological research.

ortho-Substituted C-aryl glucosides as highly potent and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors.

B. Seed, Kun-Jian Peng, A. Welihinda, 2010, Bioorganic & medicinal chemistry.

Exploration of O-spiroketal C-arylglucosides as novel and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors.

B. Seed, Kun-Jian Peng, A. Welihinda, 2009, Bioorganic & medicinal chemistry letters.

Design, synthesis, and biological evaluation of deuterated C-aryl glycoside as a potent and long-acting renal sodium-dependent glucose cotransporter 2 inhibitor for the treatment of type 2 diabetes.

J. Y. Roberge, Wei-Chang Fu, Kun-Jian Peng, 2014, Journal of medicinal chemistry.

C-aryl glucosides substituted at the 4'-position as potent and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes.

J. Y. Roberge, B. Seed, Huawei Cheng, 2011, Bioorganic & medicinal chemistry letters.

Exploration of O-spiroketal C-arylglucosides as novel and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors.

B. Seed, Kun-Jian Peng, A. Welihinda, 2009, Bioorganic & medicinal chemistry letters.